Company intelligence / Profile preview

Starwood Capital Group

Miami, Florida, United States

Ownership: Private
Employees: ~4500
Development stage: Other

Overview

Starwood Capital Group is a major global private investment firm focused on real estate, private equity, debt, and infrastructure, but is not primarily a biotech, pharma, or healthcare therapeutics developer[1][4][7]. It has over $120 billion in assets under management, with investments spanning every major real estate asset class[1][4]. The firm does have some exposure to the healthcare sector through real estate investments, such as medical office buildings and senior housing, but these are property investments, not drug or therapy development[2][8].

Industry: Investors

Beyond the preview

Go deeper on Starwood Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Starwood Capital Group.

Explore the full profile